Patient-reported outcomes (PROs) in rheumatology are not just personal lists of physical complaints or so-called "organ recitals." In fact, PROs can both guide treatment decisions in daily practice ...

Patients with rheumatoid arthritis (RA) who receive immune checkpoint inhibitor (ICI) therapy for cancer do not appear to face higher mortality compared against patients without RA receiving the same ...

With 60% to 75% of patients with rheumatoid arthritis (RA) developing other long-term conditions throughout their lifetime, the researchers underscored the importance of using multimorbidity in risk ...

Patients with rheumatoid arthritis (RA) who suffer from malnutrition were more likely to be frail and face mental health challenges. Patients with rheumatoid arthritis (RA) who are also malnourished ...

Patients with rheumatoid arthritis (RA) who received immune checkpoint inhibitors (ICIs) for cancer had no increased risk for mortality and showed no differences in cause of death compared with ...

Difficult-to-treat rheumatoid arthritis (D2T-RA) affects approximately 1 in 9 patients with RA worldwide, with nearly half of these cases demonstrating persistent inflammatory refractory RA (PIRRA), ...

Please provide your email address to receive an email when new articles are posted on . Black and Hispanic patients with rheumatoid arthritis have higher disease activity and lower self-reported ...